127 related articles for article (PubMed ID: 16056118)
1. Hepatitis C--who should be treated?
Wolfe GS
Lippincotts Case Manag; 2005; 10(4):213-6. PubMed ID: 16056118
[No Abstract] [Full Text] [Related]
2. [Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].
Yaghi C; Baz P; Koussa S; Daniel F; Haddad F; Sayegh R
Gastroenterol Clin Biol; 2005 May; 29(5):616-7. PubMed ID: 15980766
[No Abstract] [Full Text] [Related]
3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
4. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
[No Abstract] [Full Text] [Related]
5. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
6. "Hepatitis C (HCV) treatment is not a "one size fits all".
Bukeirat FA; Bukeirat MM
W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C-diagnosis and treatment.
Wolfe GS
Lippincotts Case Manag; 2005; 10(3):174-6. PubMed ID: 15931053
[No Abstract] [Full Text] [Related]
8. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
[No Abstract] [Full Text] [Related]
9. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
Acero D; Adrados M; González-Huix F; Figa M
Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
[TBL] [Abstract][Full Text] [Related]
10. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
Si CW
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
[No Abstract] [Full Text] [Related]
11. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
Puoti C; Lanzetta G; Scotti E
J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
[No Abstract] [Full Text] [Related]
12. Needle-stick exposure in the health care setting: do not forget hepatitis C!
Hoepelman AI
Neth J Med; 2000 Jul; 57(1):4-6. PubMed ID: 10862995
[No Abstract] [Full Text] [Related]
13. New combination treatment for hepatitis C is more beneficial than standard therapy, study says.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Oct; 13(20):5-6. PubMed ID: 12599388
[No Abstract] [Full Text] [Related]
14. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
Golstein PE; Delforge ML; Deviere J; Marcellin P
J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
[TBL] [Abstract][Full Text] [Related]
15. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
Misery L
J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727
[TBL] [Abstract][Full Text] [Related]
16. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.
De Vera ME; Smallwood GA; Rosado K; Davis L; Martinez E; Sharma S; Stieber AC; Heffron TG
Transplantation; 2001 Mar; 71(5):678-86. PubMed ID: 11292302
[TBL] [Abstract][Full Text] [Related]
18. Prescribing practices for the treatment of hepatitis C in a Veterans Affairs medical center.
Mangin EF; Jones WN
Am J Health Syst Pharm; 2004 Jul; 61(14):1479-82. PubMed ID: 15332696
[No Abstract] [Full Text] [Related]
19. Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology.
Kornberg A; Hommann M; Tannapfel A; Grube T; Schotte U; Scheele J
Transplant Proc; 2002 Sep; 34(6):2259-60. PubMed ID: 12270389
[No Abstract] [Full Text] [Related]
20. Interferon for hepatitis C patients with psychiatric disorders.
Rifai MA; Bozorg B; Rosenstein DL
Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
